Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA

Slow responders to tuberculosis (TB) treatment in Virginia have prolonged treatment duration and consume more programmatic resources. Diabetes is an independent risk factor for slow response and low serum anti-TB drug concentrations. Thus, a statewide initiative of early therapeutic drug monitoring...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Heysell, Scott K., Moore, Jane L., Staley, Debbie, Dodge, Denise, Houpt, Eric R.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2013
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3855970/
https://ncbi.nlm.nih.gov/pubmed/24349775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/129723
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars